<DOC>
	<DOCNO>NCT01974232</DOCNO>
	<brief_summary>This retrospective analysis child ( â‰¤21years old ) receive clinical treatment either Romiplostim Eltrombopag 2 medical center 2009-2013 . The child include study Weill Medical College Cornell University , New York , New York Children 's Hospital Orange County , Orange , California</brief_summary>
	<brief_title>A Retrospective Chart Review Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim Eltrombopag From 2009-2013</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>1 . All patient study receive prior treatment start TPO treatment include corticosteroid , IVIG , IV antiD , and/or Rituximab . 1 . Children ITP</criteria>
	<gender>All</gender>
	<minimum_age>19 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Immune Thrombocytopenia ( ITP ) , Thrombopoietin ( TPO ) agent , child , romiplostim eltrombopag</keyword>
</DOC>